Objective: The objective of this study was to evaluate the association between a specific antibody profile (anti-Smith [anti-Sm], anti-Ro, and anti-ribonucleoprotein [anti-RNP]) and the time to develop LN in SLE patients. The gene discussed is RNPC3; the disease is systemic lupus erythematosus.